Sağlık Sitelerinden Haberler


        
 
Bilgi:
Etiketler:
Yazarın adı:
Yazarın soyadı:


EklenmeTarihi: 23 Mayıs 2022, Pazartesi, 00:06
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022
This report describes how COVID-19 vaccinations and booster doses were associated with lower chances of ICU admission for hospitalized SARS-CoV-2 infected adults during Omicron predominance.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=514039
Etiketler:


EklenmeTarihi: 23 Mayıs 2022, Pazartesi, 00:06
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022
This report describes COVID-19 vaccine effectiveness time frames among people who received their first and second doses of the vaccine series, and effectiveness of third vaccine doses during both Delta- and Omicron-predominant periods.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=492999
Etiketler:


EklenmeTarihi: 23 Mayıs 2022, Pazartesi, 00:06
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
COVID-19 Vaccination Coverage and Vaccine Confidence by Sexual Orientation and Gender Identity - United States, August 29-October 30, 2021
This report describes COVID-19 vaccination coverage by sexual orientation and gender identity.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=510954
Etiketler:


EklenmeTarihi: 23 Mayıs 2022, Pazartesi, 00:06
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
SARS-CoV-2 Infection and Hospitalization Among Adults Aged ≥18 Years, by Vaccination Status, Before and During SARS-CoV-2 B.1.1.529 (Omicron) Variant Predominance - Los Angeles County, California, November 7, 2021-January 8, 2022
This report describes COVID-19 incidence and hospitalization rates during Omicron predominance in January 2022.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=508967
Etiketler:


EklenmeTarihi: 23 Mayıs 2022, Pazartesi, 00:06
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence - 25 U.S. Jurisdictions, April 4-December 25, 2021
This report describes COVID-19 incidence rate ratios for unvaccinated versus fully vaccinated persons with and without booster vaccine doses during the emergence of the Omicron variant.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=492998
Etiketler:


EklenmeTarihi: 23 Mayıs 2022, Pazartesi, 00:06
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021
This report describes COVID-19 cases and hospitalizations by vaccination status and previous COVID-19 diagnosis before and after the Delta variant became predominant.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=489676
Etiketler:


EklenmeTarihi: 23 Mayıs 2022, Pazartesi, 00:06
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults - United States, August-December 2021
This report describes the effectiveness of the third dose of Pfizer-BioNTech and Moderna vaccines in preventing hospitalizations.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=499899
Etiketler:


EklenmeTarihi: 23 Mayıs 2022, Pazartesi, 00:06
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods - United States, December 2020-January 2022
This report describes disease severity and healthcare utilization during the emergence of the Omicron variant of the virus that causes COVID-19 in the U.S.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=498091
Etiketler:


EklenmeTarihi: 23 Mayıs 2022, Pazartesi, 00:06
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices - United States, December 2021
This report describes updated recommendations from the ACIP to the use of Janssen mRNA COVID-19 vaccines.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=490924
Etiketler:


EklenmeTarihi: 23 Mayıs 2022, Pazartesi, 00:06
Bilgi: Haber Kaynağı: Çeşitli Haber Siteleri
Notes from the Field: Early Evidence of the SARS-CoV-2 B.1.1.529 (Omicron) Variant in Community Wastewater - United States, November-December 2021
This report describes early evidence of the Omicron variant in community wastewater.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=490925
Etiketler: